Recent work has revealed correlations between bacterial or viral infections and atherosclerotic disease. One particular bacterium, Chlamydia pneumoniae, has been observed at high frequency in human atherosclerotic lesions, prompting the hypothesis that infectious agents may be necessary for the initiation or progression of atherosclerosis. To determine if responses to gram-negative bacteria are necessary for atherogenesis, we first bred atherosclerosis-prone apolipoprotein (apo) E−/− (deficient) mice with animals incapable of responding to bacterial lipopolysaccharide. Atherogenesis was unaffected in doubly deficient animals. We further tested the role of infectious agents by creating a colony of germ-free apo E−/− mice. These animals are free of all microbial agents (bacterial, viral, and fungal). Atherosclerosis in germ-free animals was not measurably different from that in animals raised with ambient levels of microbial challenge. These studies show that infection is not necessary for murine atherosclerosis and that, unlike peptic ulcer, Koch's postulates cannot be fulfilled for any infectious agent in atherosclerosis.
Skip Nav Destination
Article navigation
17 April 2000
Brief Definitive Report|
April 18 2000
Infectious Agents Are Not Necessary for Murine Atherogenesis
Samuel D. Wright,
Samuel D. Wright
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Charlotte Burton,
Charlotte Burton
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Melba Hernandez,
Melba Hernandez
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Heide Hassing,
Heide Hassing
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Judy Montenegro,
Judy Montenegro
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Steve Mundt,
Steve Mundt
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Sushma Patel,
Sushma Patel
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Deborah J. Card,
Deborah J. Card
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Anne Hermanowski-Vosatka,
Anne Hermanowski-Vosatka
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
James D. Bergstrom,
James D. Bergstrom
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Carl P. Sparrow,
Carl P. Sparrow
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Patricia A. Detmers,
Patricia A. Detmers
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Yu-Sheng Chao
Yu-Sheng Chao
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Search for other works by this author on:
Samuel D. Wright
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Charlotte Burton
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Melba Hernandez
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Heide Hassing
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Judy Montenegro
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Steve Mundt
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Sushma Patel
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Deborah J. Card
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Anne Hermanowski-Vosatka
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
James D. Bergstrom
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Carl P. Sparrow
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Patricia A. Detmers
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Yu-Sheng Chao
aDepartment of Lipid Biochemsitry, Merck Research Laboratories, Rahway, New Jersey 07065
Received:
December 24 1999
Revision Requested:
December 24 1999
Accepted:
January 17 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 191 (8): 1437–1442.
Article history
Received:
December 24 1999
Revision Requested:
December 24 1999
Accepted:
January 17 2000
Citation
Samuel D. Wright, Charlotte Burton, Melba Hernandez, Heide Hassing, Judy Montenegro, Steve Mundt, Sushma Patel, Deborah J. Card, Anne Hermanowski-Vosatka, James D. Bergstrom, Carl P. Sparrow, Patricia A. Detmers, Yu-Sheng Chao; Infectious Agents Are Not Necessary for Murine Atherogenesis. J Exp Med 17 April 2000; 191 (8): 1437–1442. doi: https://doi.org/10.1084/jem.191.8.1437
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement